Cart
sales@molnova.com
ALC-0159
CAS No. 1849616-42-7
ALC-0159( —— )
Catalog No. M28735 CAS No. 1849616-42-7
ALC-0159 is a polyethylene glycol (PEG) lipid conjugate that could be used as a vaccine excipient.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 52 | In Stock |
|
| 10MG | 85 | In Stock |
|
| 25MG | 147 | In Stock |
|
| 50MG | 259 | In Stock |
|
| 100MG | 384 | In Stock |
|
| 200MG | 572 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameALC-0159
-
NoteResearch use only, not for human use.
-
Brief DescriptionALC-0159 is a polyethylene glycol (PEG) lipid conjugate that could be used as a vaccine excipient.
-
DescriptionALC-0159 is a polyethylene glycol (PEG) lipid conjugate that could be used as a vaccine excipient.(In Vitro):ALC-0159 promotes nanoparticle stabilization by a steric mechanism through its poly(ethylene glycol) (PEG) moiety.
-
In VitroALC-0159, which contributes to nanoparticle stabilization by a steric mechanism through its poly(ethylene glycol) (PEG) moiety.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorHIF-1α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1849616-42-7
-
Formula Weight——
-
Molecular Formula(C2H4O)nC31H63NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL
-
SMILESN.CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(=O)COCCOC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moreno-Manzano et al (2010) FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status. J.Biol.Chem. 285 1333
molnova catalog
related products
-
(2E)-3-(3,5-dimethox...
(2E)-3-(3,5-dimethoxyphenyl)-1-(2-methoxyphenyl)prop-2-en-1-one is a chemical compound.
-
Eliglustat hemitartr...
Eliglustat Hemitartrate, with an IC50 of 24 nM, is a specific, potent, oral active glucocerebral glycosidase inhibitor.Eliglustat tartrate shows good potency with an IC50 of 24 nM and specificity against the target enzyme.A novel inhibitor of glucosylceramide synthase (Genz-112638) and assessed its activity in a murine model of Gaucher disease (D409V/null).?Biochemical characterization of Genz-112638 showed good potency (IC(50) approximately 24nM) and specificity against the target enzyme.?
-
Prolactin Releasing ...
Prolactin Releasing Peptide (1-31), rat
